Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): April 24, 2018

 

 

Herbalife Nutrition Ltd.

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   1-32381   98-0377871

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

P.O. Box 309GT, Ugland House,

South Church Street,

Grand Cayman, Cayman Islands

  KY1-1106
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: c/o (213)745-0500

Herbalife Ltd.

Former name or former address, if changed since last report

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

Herbalife Nutrition Ltd. (the “Company”) held its 2018 Annual General Meeting of Shareholders on April 24, 2018 (the “Meeting”). The proposals voted upon at the Meeting and the final results of the shareholder vote on each proposal are set forth below. Each of the proposals is summarized in greater detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 13, 2018.

 

  (1) Election of directors.

 

    

For

    

Against

    

Abstain

    

Broker

Non-votes

 

Michael O. Johnson

     73,595,175        242,200        17,747        7,771,454  

Jeffrey T. Dunn

     71,375,233        2,471,171        8,718        7,771,454  

Dr. Richard H. Carmona

     71,175,355        2,670,958        8,808        7,771,454  

Jonathan Christodoro

     70,906,917        2,939,286        8,918        7,771,454  

Hunter C. Gary

     72,228,535        1,615,067        11,519        7,771,454  

Nicholas Graziano

     73,341,633        503,753        9,736        7,771,454  

Alan LeFevre

     73,819,426        22,911        12,784        7,771,454  

Jesse A. Lynn

     70,511,137        3,332,456        11,529        7,771,454  

Juan Miguel Mendoza

     73,018,928        822,338        13,855        7,771,454  

Michael Montelongo

     73,345,726        500,726        8,670        7,771,454  

James L. Nelson

     72,888,387        955,016        11,719        7,771,454  

Maria Otero

     73,522,599        317,168        15,354        7,771,454  

Margarita Palau-Hernandez

     73,693,468        28,780        132,874        7,771,454  

John Tartol

     73,009,755        834,029        11,338        7,771,454  

 

  (2) Approve, on an advisory basis, of the Company’s executive compensation.

 

For

 

Against

 

Abstain

 

Broker

Non-votes

73,035,344   559,192   260,586   7,771,454

 

  (3) Approve, as a special resolution, the name change of the Company from “Herbalife Ltd.” to “Herbalife Nutrition Ltd.”

 

For

 

Against

 

Abstain

 

Broker

Non-votes

81,574,701   42,033   9,842   0

 

  (4) Approve, as a special resolution, an amendment and restatement of the Company’s Amended and Restated Memorandum and Articles of Association.

 

For

 

Against

 

Abstain

 

Broker

Non-votes

73,825,918

  17,528   11,675   7,771,454


  (5) Effect a two-for-one stock split of the Company’s common shares.

 

For

 

Against

 

Abstain

 

Broker

Non-votes

80,981,780

  637,424   7,372   0

 

  (6) Ratification of the Company’s independent registered public accountants for fiscal 2018.

 

For

 

Against

 

Abstain

 

Broker

Non-votes

81,580,531

  27,488   18,556   0


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

Herbalife Nutrition Ltd.

April 27, 2018

    By:  

/s/ John G. DeSimone

      Name: John G. DeSimone
     

Title: Chief Financial Officer